Literature DB >> 21691951

Medical treatment of classic and nonclassic congenital adrenal hyperplasia.

Phyllis W Speiser1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21691951     DOI： 10.1007/978-1-4419-8002-1_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

Review 1.  The molecular basis of blood pressure variation.

Authors:  Hakan R Toka; Jacob M Koshy; Ali Hariri
Journal:  Pediatr Nephrol       Date:  2012-07-05       Impact factor: 3.714

Review 2.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

3.  Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.

Authors:  Helmuth G Dörr; Hartmut A Wollmann; Berthold P Hauffa; Joachim Woelfle
Journal:  BMC Endocr Disord       Date:  2018-06-08       Impact factor: 2.763
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.